Botensilimab (anti-CTLA4), a human anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) monoclonal antibody, is an innate and adaptive immune activator. Botensilimab (anti-CTLA4) can be used for the research of cancer.Purity≥95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
Specification: Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC), Lot by Lot
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/AB182918-SCI_db30f804a4b0b586702b3608c0549c77.pdf
- UPC:
- 51201569
- Condition:
- New
- Availability:
- 5-10 days
- Weight:
- 0.07 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- Ab182918-5mg
- CAS:
- 2408310-37-0
- Product Size:
- 5mg